Our industry
Pierre VENESQUE
Senior Executive Vice-President Industry
“To respond to developments in patients’ expectations, we are developing an agile industrial strategy through the commitment of our teams, the adaptation of our industrial tools, and our organization. Our clients’ satisfaction depends on the quality of our drugs, and our reliability and competitiveness, which create value for our Group.“
Our quality policy, in force at each of our 16 production sites worldwide, is what makes it possible for us to honor our commitment
- Poland
- China
- Russia
- Brazil
- Egypt
- Morocco
- Spain
- Ireland
- France
- Nigeria
- Hungary
1
billion boxes
distributed per year